Health ❯ Pharmaceuticals

Generic Drugs

Semaglutide Diabetes Treatment Market Dynamics FDA Regulations Atorvastatin Access to Medicines Cost Plus Drugs Market Impact Multiple Sclerosis Treatments US Government Programs Regulatory Issues Efficacy Concerns Biosimilars Cardiovascular Medications Weight Loss Medications Market Availability Supply Chain Drug Pricing US Market Impact Market Trends Safety Reviews Market Access Drug Manufacturing Cancer Treatment Weight Loss Global Production Company Profiles Oncological Drugs Diabetes Medications Regulatory Processes GLP-1 Receptor Agonists Patents Chemotherapy US-India Pharmaceutical Trade Market Demand Market Supply Tariffs Bioequivalence Pricing Strategies

Sildenafil Shows Promise in Lab Tests to Limit Cancer Spread

Identifying a cholesterol‑export blockade in tumor cells, the study calls for clinical trials to test whether the existing drug can reduce metastasis in patients.

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 142,000 Bottles of Ascend’s Atorvastatin

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom